Supercomputers joined the fight against antibiotic resistance – EurekAlert

The participating researchers work at the Ruhr-Universitt Bochum (RUB), the University of Duisburg-Essen (UDE) in Germany, the University of Portsmouth, UK, as well as at the University of Queensland in Australia and the Weizmann Institute in Israel.

Development of new antibiotics difficult

Developing a new antibiotic is particularly difficult and very few new classes of antibiotics have been developed since the 1960s. In the current study, the researchers follow another approach. They do not develop a completely new type, but start from an already existing antibiotic, which they then modify. To do this, they used a strategy in which they simulated computationally several aspects of the candidates. Among other things, how soluble the antibiotic is, how effectively it penetrates the bacterial membrane and how efficiently it blocks the pathogens' protein production are important for its effectiveness. "The computational evaluation of whether a chemical compound will be active before it is actually synthesised avoids chemical waste." explains Professor Frank Schulz from RESOLV at RUB.

Head-to-head

The past has shown that often not much time passes before resistance to a new antibiotic emerges. Thus, it is to be expected that the bacteria will develop counterstrategies against the researchers' counterstrategies and become resistant to the new antibiotic variant. "Our hope with this study is to show that the resistance mechanisms of bacteria can be addressed in a systematic way with computational strategies that help to make the development of new antibiotic derivatives faster and more affordable" explains Professor Elsa Sanchez-Garcia, head of the Computational Biochemistry group at the UDE and Principal Investigator of RESOLV. "In this way, science can continuously fight back with the computer-assisted development of new antibiotics."

Promising candidate

The results of the supercomputer calculations were tested experimentally. In the study, the research team not only implemented the computer-based simulation approach, but also presented a new promising drug candidate. The drug candidate, which still must be clinically tested, was shown to be up to 56 times more active for the tested bacterial strains than two known antibiotics that are on the World Health Organisation's list of essential medicines. The new antibiotic variant is not only more effective against the target organisms tested, but also shows activity against the three highest ranked bacteria on the World Health Organization's priority list, for which the existing antibiotics tested are not effective. In addition to this success, a library of compounds with antibacterial activity was created, which allows for faster iteration in the development of further antibiotic variants.

Proceedings of the National Academy of Sciences

Rational prioritization strategy allows the design of macrolide derivatives that overcome antibiotic resistance

16-Nov-2021

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Read more from the original source:
Supercomputers joined the fight against antibiotic resistance - EurekAlert

What the First Two Laws of Thermodynamics Are and Why They Matter – Interesting Engineering

Thermodynamics is the branch of physics that studies the relationship between heat and other forms of energy. It's especially focused on energy transfer and conversion and has a lot to contribute to the fields of chemical and mechanical engineering, physical chemistry, and biochemistry.

The term thermodynamics was likely first coined by mathematical physicist William Thompson, also known as Lord Kelvin, in his paper On the Dynamical Theory of Heat (1854).

Modern thermodynamics is based on four laws:

In this article, well be focusing on the first and second laws of thermodynamics.

The first law of thermodynamics is also known as the law of conservation of energy. Given that the energy cant be created or destroyed, the total energy of an isolated system will always be constant because, and can only be converted into another form of energy or transferred somewhere else in the system.

The formula of the first law of thermodynamics is U = Q W, where U is the change in internal energy U of the system, Q is the net heat transferred into the system (the sum of all the heat transfers of the system), and W is the net work done by the system (the sum of all work performed on or by the system).

The second law introduces the concept of entropy in thermodynamics. Entropy is a physical property that measures the amount of thermal energy in a system that is unavailable for doing useful work. The energy that cant do work turns into heat, and the heat increases the molecular disorder of the system. Entropy can also be thought of as a measurement of that disorder.

The second law of thermodynamics states that entropy is always increasing. This is because, in any isolated system, there is always a certain amount of energy that is not available to do work. Consequently, heat will always be produced and this naturally increases the disorder (or entropy) of the system.

The increasing entropy (S) equates to the heat transfer (Q) divided by the temperature (T). This is why the second law of thermodynamics can be expressed with the formula S =Q / T.

As stated above, the first law of thermodynamics closely relates to the law of conservation of energy, which was first expressed by Julius Robert Mayer in 1842.Mayer realized that a chemical reaction produces heat and work and that work can then produce a definite amount of heat. Although this is essentially a statement of the conservation of energy, Mayer was not part of the scientific establishment, and his work was ignored for some years.

Instead, German physicist Rudolf Clausius, Irish mathematician William Thomson (Lord Kelvin), and Scottish mechanical engineer William Rankine would have a greater role in developing the science of thermodynamics and adapting the conservation of energy to thermodynamic processes, starting in around 1850.

The second law of thermodynamics has its origin in the work of French mechanical engineerNicolas Lonard Sadi Carnot, who studied steam engines. He is often considered the father of thermodynamics due to his book Reflections on the Motive Power of Fire (1824),which presented a theoretical discussion of the perfect (but unattainable) heat engine Motive power is what wed call work nowadays, and fire refers to heat.

In this book, Sadi Carnot wrote an early statement of the second law of thermodynamics, which was reformulated by Rudolf Clausius more than forty years later. Other scientists also contributed to defining the law: the aforementioned Lord Kelvin (1851), German mathematician Max Planck (1897), and Greek mathematician Constantin Carathodory (1909).

According to thermal science researcher Jayaraman Srinivasan, the discovery of the first and second laws of thermodynamics was revolutionary in the physics of the 19th Century.

The third law of thermodynamics was developed by German chemist Walther Nernst at the beginning of the 20th century. Nernst demonstrated that the maximum work obtainable from a process could be calculated from the heat evolved at temperatures close to absolute zero. The zeroth law had been studied since the 1870s but was defined as a separate law during the 1900s.

The first and second laws of thermodynamics are independent of each other because the law of entropy is not directly derived or deduced from the law of conservation of energy or vice versa.

But at the same time, the two laws complement each other because, while the first law of thermodynamics includes the transfer or transformation of energy, the second law of thermodynamics talks about the directionality of physical changes how isolated or closed systems move from lower to higher entropy due to the energy that cant be used for work.

In other words, the second law of thermodynamics takes into account the fact that the energy transformation described in the first law of thermodynamics always releases some extra, useless energy that cant be converted into work.

The laws of physics explain how natural phenomena and machines work. These explanations not only satisfy our curiosity but also allow us to predict phenomena. In fact, they are instrumental in allowing us to build functional machinery.

As a branch of physics, thermodynamics is no exception for this. If you know how much energy in a system can be used for work, and how much will turn into heat (and theres always a certain amount of useless energy in a system), you can predict how much heat a given machine will produce under different conditions. Then, you can decide what to do with that heat.

Heat is a form of energy and if you know that energy cant be destroyed but only transformed, you could find a way to turn that thermal energy into mechanical energy which is what, in fact, heat engines do.

Given this basic application of the first and second laws of thermodynamics, you can probably imagine how useful they can be in the engineering field. But they can also have applications in chemistry, cosmology (entropy predicts the eventual heat death of the universe), atmospheric sciences, biology (plants convert radiant energy into chemical energy during photosynthesis), and many other fields. Hence the importance of thermodynamics

To break the first law of thermodynamics, wed have to create a "perpetual motion" machine that worked continuously without the input of any kind of power. That doesnt exist yet. All the machines that we know receive energy from a source (thermal, mechanical, electrical, chemical, etc.) and transform it into another form of energy. For example, steam engines convert thermal energy into mechanical energy.

To break the first law of thermodynamics, life itself would have to be reimagined. Living things also exist in concordance with the law of conservation of energy. Plants use photosynthesis to make food (chemical energy for their use) and animals and humans eat to survive.

Eating is basically extracting energy from food and converting it into chemical energy (stored as glucose) which is what actually gives us energy. We turn that chemical energy into mechanical energy when we move, and into thermal energy when we regulate our bodys temperature, etc.

But things may be a bit different in the quantum world. In 2002, chemical physicists of the Australian National University in Canberra demonstrated that the second law of thermodynamics can be briefly violated at the atomic scale. The scientists put latex beads in water and trapped them with a precise laser beam. Regularly measuring the movement of the beads and the entropy of the system, they observed that the change in entropy was negative over time intervals of a few tenths of a second.

More recently, researchers, including some working on Googles quantum processor Sycamore, created "time crystals", an out of equilibrium phase of matter cycling indefinitely between two energy states without losing any energy to the environment. These nanoparticles never reach thermal equilibrium. They form a quantum system that does not appear to increase its entropy which totally violates the second law of thermodynamics.

This is a real-life demonstration of Maxwell's demon, a thought experiment to break the second law of thermodynamics.

Proposed by Scottish mathematician James Clerk Maxwell in 1867, the experiment consisted of putting a demon in the middle of two chambers of gas. The demon controlled a massless door that allowed the chambers to exchange gas molecules. But given that the demon opened and closed the door so quickly, only fast-moving molecules passed through in one direction, and only slow-moving molecules passed through in the other. This way, one chamber heated up and the other cooled down, diminishing the total entropy of the two gases without involving work.

Although we still dont know exactly how to use time crystals, it is already considered a revolutionary discovery in condensed matter physics. Time crystals could, at the very least, significantly improve quantum computing technology.

But theres also something about the concept of perpetual motion without using any energy that unavoidably leads futuristic minds to imagine perpetual motion quantum devices which wont require any additional input of energy such as an unplugged refrigerator that is still able to cool your food down; or more science-fictiony, a supercomputer sustaining the simulation we could be living in.

Read the original post:
What the First Two Laws of Thermodynamics Are and Why They Matter - Interesting Engineering

IDF ranks Pakistan third in prevalence of diabetes – The Nation

KARACHI - Professor Dr Shamim Qureshi from Department of Biochemistry, University of Karachi said that the International Diabetes Federation (IDF) has ranked Pakistan as third in the prevalence of diabetes following China and India.

According to the IDF, around 33 million people in the country are living with diabetes. These views were expressed by Professor Dr Shamim, while addressing a seminar entitled Access to Diabetes Care here on Wednesday.

The department of biochemistry in collaboration with the University of Karachi Alumni Association (UKAA) Baltimore, Washington, USA organized a poster competition and seminar in connection with World Diabetes Day.

Overall, more than 537 million people are suffering from diabetes across the globe. During the Covid-19 lockdown, we have seen an increase in the prevalence of type-II diabetes around the world as well as in Pakistan as the pandemic has restricted physical activities and obesity was seen on the raise during the pandemic duration, she informed.

She informed the audience that this is very alarming that the country has been witnessing so many people with diabetes and still not taking it seriously.

Dr Abbasi highlighted the significance of standardization of health care establishments and their services in his talk. He said that the Second National Diabetic survey revealed the prevalence of diabetes is 26.19 percent among people over 20 years of age.

He mentioned that it means that every fourth person is diabetic in the country. He stated that health facilities are insufficient and diabetes supplies are not regular. He emphasized structured training of health care providers to cope with the huge burden of diabetes at one end and ensuring uninterrupted affordable diabetes supply at the other. He reiterated that an all-out approach with the right efforts is required on a priority basis.

Dr Abbasi was of the opinion that policymakers and authorities must give due recognition to the fact that more prevention and good control of diabetes will reduce the workload of other specialtiesoriented facilities like cardiac hospitals, kidney hospitals, and neurological centers.

Consultant Dietitian Mariam Abde Ali gave a good account of the implications of a balanced diet on the health of diabetes patients. She said that a healthy diet ensures good health. The success of dietary management in diabetes care depends upon flexibility, portion control, and consistency.

She shared that better lifestyle choice on an all-time basis leads to desired results of medical nutrition therapy. She advised that body weight has to be controlled and maintained in order to keep the body mass index (BMI) below 25 kg/m2.

On this occasion, Dr Tooba Lateef conducted self-health assessment activity through a mobile app called NutriApp (T gamma developers) among participants. Through which participants curiously knew their ideal body weight, BMI, waist to hip ratio, recommended calories, and fluid intake.

She mentioned that these are the key factors in planning a healthy diet to be fit. Dr Shershah Syed, the renowned gynecologist and surgeon, and Dr Sadaf Ahmed, Chief Executive Officer of Advanced Education Institute and Research Center were the chief guests of the event. Both of them emphasized the importance of education for youth especially females. They stated that education is the key for getting awareness not only for any disease including diabetes but also it helps to handle any problem which youth face in their social life.

The final year of students of the biochemistry department (Morning and Evening Program) actively participated in the poster competition and made colorful posters regarding awareness of diabetes and its complications, the judgment of this competition was done by Dr Hina Mudassir (Chairperson, Department of Biochemistry, Federal Urdu University of Arts, Science and Technology), Dr Musarrat Jahan (Assistant Professor, Human Nutrition and Dietetics, Ziauddin Medical University) and Dr Arisha Salman (Assistant Professor, Department of Biochemistry, Dow International Medical College).

The competition was won by Ayesha Shahbaz and received the first prize of Rs3000/- cash while a special prize of Rs1500/- cash was received by Maryum Laiquat, Rida Qamar, Hafiza Fatima Zehra, Ayesha Mustaqim, and Bakhtawar.

During the event diabetes camp to assess free blood sugar and bone mass density BMD) was also arranged by Dr Essa Diagnostic Laboratory in the department of biochemistry. Other speakers of the seminar were Dr Muhammad Zafar Iqbal Abbasi from Baqai Institute of Diabetology and Endocrinology, Mariam Abdeali, Consultant Dietitian and Dr Tooba Lateef, Assistant Professor, Department of Biochemistry.

Read more:
IDF ranks Pakistan third in prevalence of diabetes - The Nation

Infectious Disease Diagnostic Market Cumulative Impact for COVID-19 Recovery Research Report 2021 | Johnson & Johnson, Roche, Beijing Leadman…

Infectious Disease Diagnostic Market report focused on the comprehensive analysis of current and future prospects of the Infectious Disease Diagnostic industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Infectious Disease Diagnostic market has been done in order to calculate the growth rates for each segment and sub-segments.

The global Infectious Disease Diagnostic Market is expected to grow at a significant CAGR of 6.8% by 2028.

Infectious disease diagnosis is defined as a laboratory test, which is executed with the help of skilled technicians and physicians to diagnose infectious diseases. It is a diagnostic procedure in which the causative organism of an infectious disease is characterized and identified. The sample of urine, blood, mucus, or other body fluids are analyzed to provide information about the causative organism by the use of various diagnosis procedure and instruments.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report: https://www.a2zmarketresearch.com/sample-request/515621

Top Key Vendors of this Market are:

Johnson & Johnson, Roche, Beijing Leadman Biochemistry, Grifols, KHB, BD, BioSino Bio-technology, Mindray, Bioekon, Sichuan Maccura Biotechnology, Abbott, Shanghai Kehua Bio-engineering, Siemens, Beijing Strong Biotechnologies, Fusun Pharma, Beckman, BioMerieux, Sysmex, DAAN Gene, Randox, Bio-Rad, DIAN DIAGNOSTICS.

Global Infectious Disease Diagnostic Market Segmentation:

Market Segmentation: By Type

Molecular Diagnostic Technique, Traditional Diagnostic Technique

Market Segmentation: By Application

Hospital, Clinic, Research

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Infectious Disease Diagnostic market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Infectious Disease Diagnostic market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Infectious Disease Diagnostic market.

Get Special Pricing on this Premium Report: https://www.a2zmarketresearch.com/discount/515621

The influence of the latest government guidelines is also analysed in detail in the report. It studies the Infectious Disease Diagnostic markets trajectory between forecast periods. The cost analysis of the Global Infectious Disease Diagnostic Market has been performed while keeping in view manufacturing expenses, labour cost, and raw materials and their market concentration rate, suppliers, and price trend.

Reasons for buying this report:

Table of Contents

Global Infectious Disease Diagnostic Market Research Report 2021 2027

Chapter 1 Infectious Disease Diagnostic Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Infectious Disease Diagnostic Market Forecast

Buy Exclusive Report: https://www.a2zmarketresearch.com/checkout

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

See the article here:
Infectious Disease Diagnostic Market Cumulative Impact for COVID-19 Recovery Research Report 2021 | Johnson & Johnson, Roche, Beijing Leadman...

Oncology meets immunology: the cancer-immunity cycle

The genetic and cellular alterations that define cancer provide the immune system with the means to generate T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of nonself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, including PD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hinders immune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune responses. The presence of suppressive factors in the tumor microenvironment may explain the limited activity observed with previous immune-based therapies and why these therapies may be more effective in combination with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immunotherapy is likely to become a key part of the clinical management of cancer.

Go here to see the original:
Oncology meets immunology: the cancer-immunity cycle

Robert Koch Prize in Microbiology and Immunology Goes to Andreas Bumler – UC Davis

Microbiologist Andreas Bumler of the School of Medicine and the College of Biological Sciences has been named a recipient of the 2021 Robert Koch Prize, given by Germanys Robert Koch Foundation for achievement in microbiology and immunology a prize that is considered one of the most prestigious awards in science.

Bumler is a professor and vice chair of research in the Department of Medical Microbiology and Immunology, and also affiliated with four graduate groups: Microbiology; Immunology; Integrative Pathobiology; and Biochemistry, Molecular, Cellular and Developmental Biology.

He shares the prize with Yasmine Belkaid, immunologist and senior investigator at the National Institute of Allergy and Infectious Diseases, and adjunct professor at the University of Pennsylvania.

The Robert Koch Prize is shared this year to recognize groundbreaking research that shows how, on the one hand, our microflora train our immune system, and on the other hand, our intestinal epithelium determines the composition of our microflora, and what role disruptions of this dialogue between microflora and us play in infectious and inflammatory diseases, the foundation said in a news release.

UC Davis Professor Satya Dandekar, chair of the Department of Medical Microbiology and Immunology, said: Dr. Bumler has made seminal contributions for advancing our knowledge of the microbial dysbiosis during gut inflammatory infections. He is an exceptional scientist and a great mentor to junior researchers.

The award ceremony is scheduled for Nov. 19 in Berlin. As of today (Nov. 8), the prize of 120,000 euros is the equivalent of $139,075.

Wolfgang Plischke, chair of the Robert Koch Foundation, said: At a time when science and research are constantly at the center of public interest and are often the subject of unfiltered discussion on social networks, it is more important than ever to honor the hard work, unwavering diligence and thirst for knowledge of all the men and women who have dedicated their lives to medicine and biology.

Robert Koch (18431910), after whom the prize is named, founded modern bacteriology. For this he received the Nobel Prize for Medicine and Physiology in 1905. Koch headed the Institute for Infectious Diseases in Berlin from 1891 until his retirement in 1904.

View original post here:
Robert Koch Prize in Microbiology and Immunology Goes to Andreas Bumler - UC Davis

The Science Behind COVID-19 Vaccines & Immunology – News | University Communication | Nebraska

Increase your understanding of the science behind biology and immunology, along with how scientists use that information to develop vaccines and how these vaccines work in our bodies. Plan to attend this interesting and informal educational session with Dr. Angie Pannier, a biomedical engineer and expert in nucleic acid vaccines, and Dr. Amanda Ramer-Tait, an immunologist and expert on host-microbe interactions.

Whether youre a budding researcher yourself or youd like to increase your scientific knowledge to share with family and friends, this session will break down the basics of how vaccines work. The first 45 minutes will provide an overview and the second half of the session will offer time for Q&A.

Read the original:
The Science Behind COVID-19 Vaccines & Immunology - News | University Communication | Nebraska

Biovaxys says CoviDTH shows safety and tolerability in pathology and immunology evaluations – Proactive Investors USA & Canada

BioVaxys Technology Corp Chief Medical Officer David Berd joined Proactive to discuss results from its in vivo animal research study support the safety and tolerability of CoviDTH at two intradermal dose levels across a battery of clinical pathology, immunology, and histopathology evaluations.

CoviDTH is the world's first and only low-cost, disposable, point-of-care diagnostic tool that screens for a T-cell response to SARS-CoV-2, the virus that causes coronavirus, according to BioVaxys.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

Read the original:
Biovaxys says CoviDTH shows safety and tolerability in pathology and immunology evaluations - Proactive Investors USA & Canada

Correction for Wolfsberger et al., TAp73 represses NF-Bmediated recruitment of tumor-associated macrophages in breast cancer – pnas.org

IMMUNOLOGY AND INFLAMMATION Correction for TAp73 represses NF-Bmediated recruitment of tumor-associated macrophages in breast cancer, by Johanna Wolfsberger, Habib A. M. Sakil, Leilei Zhou, Niek van Bree, Elena Baldisseri, Sabrina de Souza Ferreira, Veronica Zubillaga, Marina Stantic, Nicolas Fritz, Johan Hartman, Charlotte Rolny, and Margareta T. Wilhelm, which published March 1, 2021; 10.1073/pnas.2017089118 (Proc. Natl. Acad. Sci. U.S.A. 118, e2017089118).

The authors note that Supporting Table S2 in the SI Appendix appeared incorrectly. Regarding this error, the authors note, Sanger sequencing primers for the mouse and human Ccl2 gene have mistakenly been entered in the qPCR primer table (SI Appendix, Table S2) instead of the qPCR primer sequences for Ccl2 that were used in this study.

The authors also note that an error appeared in Fig. 3 and Fig. S3 in the SI Appendix. In both figures, the histograms are labeled DMSO but should instead be labeled siCtrl. The corrected figure and its legend appear below. The online version has been corrected, including the SI Appendix with the corrected Table S2 and Fig. S3.

TAp73 represses NF-Bmediated regulation of Ccl2 expression. (A) qRT-PCR analysis of Ccl2 mRNA levels in (A) TAp73 WT and KO MEFE1A/Ras (n = 3) and (B) PyMT/TAp73 WT or KO cells (n = 4) after 16-h treatment with NF-B inhibitor SC-514 (100 g/mL). ELISA analysis of Ccl2 protein secretion in conditioned media from (C) TAp73 WT and KO MEFE1A/Ras (n = 3) and (D) PyMT/TAp73 WT or KO cells (n = 4) after 16-h treatment with SC-514 (100 g/mL). (E and F) qRT-PCR analysis of Ccl2 mRNA levels in (E) TAp73 WT and KO MEFE1A/Ras (n = 3) and (F) PyMT/TAp73 WT or KO cells (n = 3) after 48-h treatment with sip65/RELA. (G and H) ELISA analysis of Ccl2 protein secretion in conditioned media from (G) TAp73 WT and KO MEFE1A/Ras (n = 3) and (H) PyMT/TAp73 WT or KO cells (n = 3) after 48-h treatment with sip65/RELA. (I) Schematics showing the murine Ccl2 promoter including NF-B response elements, of which the distal BSs 3 and 4 were deleted either individually or simultaneously. (J) WT or mutated Ccl2 promoter luciferase reporter was cotransfected with TAp73 in HEK293 cells. Luciferase activity was measured 24 h after transfection and normalized to mock control (n = 6). All data are shown as mean SD *P < 0.05, **P < 0.01, ****P < 0.0001.

See the original post:
Correction for Wolfsberger et al., TAp73 represses NF-Bmediated recruitment of tumor-associated macrophages in breast cancer - pnas.org

Fight Misinformation With Anticipation, Facts, and Curiosity – Medscape

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

With the Delta variant taking hold and COVID cases on the rise in mid-July, US Surgeon General Vivek Murthy, MD, MBA, released an advisory declaring that misinformation was a serious health threat and urging Americans to help slow its spread during the pandemic and beyond.

Last weekend, speakers at the American College of Allergy, Asthma, and Immunology (ACAAI) 2021 Annual Meeting, in New Orleans, Louisiana, issued a similar call to arms. "We have to take advantage of the very special role that we all play in the lives of our patients," said David Stukus, MD, an allergist-immunologist and professor of clinical pediatrics at Nationwide Children's Hospital, Columbus, Ohio. "We want to use that trust that we've developed with them to help combat misinformation."

According to a poll conducted by the Kaiser Family Foundation, personal doctors and pediatricians topped the list of trusted sources for reliable COVID-19 vaccine information, Gerald Lee, MD, associate professor of pediatrics at Emory University School of Medicine, Atlanta, Georgia, told attendees.

Social media usage has soared over the past decade. Today, 7 in 10 Facebook users say they visit the site daily, and nearly 80% of Americans who regularly get news on Snapchat and TikTok view social media as an important source of vaccine news, according to Pew Research Center data that Lee presented at the meeting.

Although research shows that most people do a decent job discriminating truth from fake news, when it comes to sharing news on social media platforms, that discernment drops considerably. "Users share misinformation without considering accuracy," said Lee, citing a March 2021 study published in Nature. Social media algorithms tend to promote content that is emotionally engaging. This amplification allows "a small number of activists to achieve influence," Lee said. Their continued, repetitive messaging "perpetuates misinformation to being accepted by the public," he said.

Anne Ellis, MD, chair of allergy and immunology at Queen's University, in Kingston, Ontario, Canada, called for vigilance among allergy practitioners to fight the cycle of misinformation and not let fake news shape medical decision making. "Make facts your hook when you're talking to patients" and explain that "science is an evolving process," Ellis said at ACAAI.

"Providing facts not only helps patients trust and value their provider's input, but facts also help patients challenge anxiety-provoking information they may have learned via social media," Tamara Hubbard, LCPC, told Medscape Medical News. Hubbard, a licensed counselor in the Chicago area, works with food-allergy families and maintains a resource website that includes an international directory of allergy-informed clinical therapists.

Stukus encouraged physicians to anticipate patients' confusion and to be proactive about engaging people on these topics. "Ask questions," he said. "See if they have any concerns about health-related information or about things impacting their allergic conditions." Observe nonverbal cues, he said. For example, when asking patients whether they have concerns about the COVID vaccine, "they may say no, but their body may say something different." Then, he said, take time "to dive into the nuance."

In addition, he advised clinicians to bear in mind the fact that many patients have trouble comprehending risk and to seek different ways to convey health information. "It's one thing to say only five out of a million people have anaphylaxis to COVID vaccines," Stukus said. "You can also state that 999,995 people out of the million didn't have anaphylaxis when they got a COVID vaccine. Some people need to hear that."

He advised that when conversations wander into unfamiliar territory, one should be humble and transparent. If a patient throws a stumper, "I say, 'I honestly don't know. But you've given me an assignment that I'll happily take on, so I can give you the right information about that particular question you just asked,' " Ellis said.

Stukus has consulted for Before Brands, Integrity CE, and Kaleo; works as social media editor for the American Academy of Allergy, Asthma and Immunology (AAAAI) and is associate editor for Annals of Allergy, Asthma and Immunology; and receives honoraria from the American College of Allergy, Asthma and Immunology (ACAAI), the American Academy of Pediatrics, and AAAAI. Ellis has received an honorarium from AstraZeneca to give webinars on managing allergic and adverse reactions to COVID-19 vaccines. Lee reports no relevant financial relationships. Hubbard is an allied health member of ACAAI and AAAAI and completed a paid project for the nonprofit organization Food Allergy Research and Education.

American College of Allergy, Asthma, and Immunology (ACAAI) 2021 Annual Meeting: Presented November 6, 2021.

Esther Landhuis is a freelance science journalist in the San Francisco Bay Area. She can be found on Twitter @elandhuis.

For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube.

Read this article:
Fight Misinformation With Anticipation, Facts, and Curiosity - Medscape